"Designing Growth Strategies is in our DNA"
The global subdural electrode market size stood at USD 28.5 Million in 2018 and is projected to reach USD 53.2 Million by 2026, exhibiting a CAGR of 8.1% during the forecast period.
Subdural electrodes are predominantly used for intracranial monitoring in the pre-surgical phase of epilepsy. Intracranial monitoring is conducted in patients experiencing seizures and epileptic episodes. Moreover, these procedures are carried out in patients who fail to respond to epilepsy medications and require surgery. If the focus of seizures is believed to be on the surface of the brain, subdural electrodes are preferred, while if the focus on seizures is believed to be in the brain, depth electrodes are recommended for intracranial monitoring.
An increasing number of epilepsy surgeries coupled with the rising adoption of intracranial monitoring and prevalence of epilepsy is anticipated to boost the subdural electrode market growth during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), in the U.S., the number of adults suffering from epilepsy grew from 2.3 million in 2010 to 3 million in 2015. Additionally, the expansion of research and development activities in the epilepsy seizure detection technologies is projected to offer lucrative growth for the market by 2026.
Request a Free sample to learn more about this report.
The market for subdural electrodes is witnessing several technological advancements and trends. The adoption of subdural electrodes is expected to witness growth in developed and developing countries owing to the benefits served, such as superior visualizations, detection of seizure locations, and increasing healthcare infrastructure.
“Increasing Demand for Innovative Epilepsy Care to Boost Growth”
The increasing number of epileptic patients are creating a lucrative opportunity for the number of surgeries and hence, intracranial monitoring as it is pre-surgical planning process for epilepsy surgery. Moreover, the gradual shift in preference of epileptic patients from anti-epileptic drugs (AEDs) to epilepsy surgery is projected to offer significant opportunity for the growth of the market by 2026.
The increasing demand for advanced epilepsy care is encouraging research and development activities. Combined with this, active government contribution and an increasing association of market players and healthcare facilities is anticipated to elevate the growth of the market during the forecast period. For instance, in April 2019, the government of Australia announced financial aid of an estimated USD 20.0 Million over four years to support people living with epilepsy in the region. The program is expected to encourage research & development activities and access to epilepsy treatment facilities for epileptic patients.
“Superior Procedural Outcomes of Electrodes for Locating Seizure Focus in Epilepsy”
According to a study published in the Brain Sciences journal in 2018, around 30.0% of the patients consuming anti-epileptic medications across the globe fail to get desired treatment outcomes for epilepsy seizure control. Intracranial monitoring is performed in order to locate the seizure focus in epileptic patients. Higher precision in locating seizure focus, effective brain mapping, and real-time brain activity monitoring are anticipated to substantially drive the growth of the subdural electrodes market during 2019-2026.
“Depth (SEEG) Electrodes Segment to Dominate the Market”
In terms of type, the market is categorized into strip, grid, depth, and others. The depth electrode segment is estimated to account for the maximum portion of the market. Certain factors such as comprehensive recording of deep brain structures, minimal invasion, improved patient comfort, and four-dimensional brain visualizations are expected to accelerate the growth of the depth electrodes segment in the subdural electrodes market during the forecast period.
To know how our report can help streamline your business, Speak to Analyst
The grid segment is expected to propel due to the significant opportunity for the growth of the adoption of subdural electrodes in emerging nations. Moreover, higher utilization of cortical electrodes (strip and grid electrodes) in research activities is anticipated to offer considerable growth for these electrodes during 2019-2026.
“Higher Bio-compatibility to Boost the Adoption of Platinum Electrodes”
On the basis of material, the market can be segmented into platinum and stainless steel. In terms of revenue, the platinum segment is estimated to dominate the market owing to the higher bio-compatibility of platinum and lower infection rate. Furthermore, extended benefits offered by platinum electrodes, such as higher accuracy in seizure location detection due to superior electrical conductivity and lower intracranial pressure is projected to drive the growth of this platinum segment during the forecast period. Stainless steel segment is also expected to register significant CAGR owing to the probability of its adoption in emerging nations.
“Growing Demand for Advanced Healthcare Facilities is Projected to Drive Hospitals Segment”
On the basis of the end user, the market is segmented into hospitals, specialty clinics, and others. The hospitals segment is estimated to dominate the market throughout the forecast period. Increasing demand for advanced healthcare facilities for epilepsy care in emerging nations and increasing awareness about intracranial monitoring in amongst healthcare resources would affect growth of the segment positively. Also, the rising emphasis on epilepsy surgeries due to better procedural outcomes is expected to drive the growth of the hospital segment during the forecast period.
Combined with this, an increasing number of epilepsy centers across the globe is projected to offer significant growth for the specialty clinics segment during the forecast period. For instance, the Neurological Society of India, in a study, published that in 2017, the number of epilepsy treatment and research centers grew from 33 in 2012 to 39 in 2015. The others segment, which includes research centers is anticipated to expand owing to the extensive number of research and development activities in the field of brain mapping for epilepsy.
The U.S. generated a revenue of USD 11.4 Million in 2018 and is projected to dominate the market throughout the forecast period. Presence of major market players, strategic collaborations, and higher awareness about subdural electrodes are the major factors that are attributable to the dominance of the U.S. in the global market. Combined with this, an increasing prevalence of epilepsy in the U.S. is anticipated to drive the growth of the market during the forecast period in this region. For instance, according to a study published on NCBI in 2015, the prevalence of epilepsy in the U.S. grew by an estimated 4.7% during 2010 to 2015.
In Europe, improved healthcare facilities for epilepsy, higher adoption of depth electrodes, and increasing awareness of intracranial monitoring in the European nations such as the U.K., France, Germany, and others are attributable to the significant share of Europe in the global market. Additionally, supportive government activities are also expected to contribute in the growth of the Europe electrocorticography (ECoG) electrodes market. For instance, the commencement of E-PILEPSY, which was announced in 2014 by the European Union is expected to strengthen the infrastructure for epilepsy surgery in Europe, which will eventually boost the subdural electrode market growth in Europe.
In the rest of the world, high treatment gap for epilepsy generates huge opportunity for the growth of the market. For instance, according to a study conducted by the National Institute of Mental Health and Neurosciences, India, in 2014, the treatment gap in rural India was an estimated 90.0%, while that of in urban India was of 22.0%. Moreover, there was huge gap in the number of epilepsy centers and the prevalence of epilepsy India. This is projected to augment the market in the rest of the world during the forecast period. Technological advancements, increasing healthcare spending, and the expected expansion of distribution network of key players in Japan are some of the primary factors augmenting the subdural electrodes market in Japan.
“AD Tech Medical Instrument Corporation, CorTec GmbH, and Integra Lifesciences Corporation to Lead the Market.”
The subdural electrode market is a highly consolidated market as a limited number of players hold majority of the market share. In 2018, AD Tech Medical Instrument Corporation, CorTec GmbH, and Integra Lifesciences Corporation held majority of the market share. In terms of revenues, AD Tech Medical Instrument Corporation accounted for the major share, which is mainly due to strong brand presence and comparatively consolidated distribution channel. The market share of CorTec GmbH and Integra Lifesciences Corporation is estimated to increase owing to the focus on strategic collaborations with healthcare institutions and emphasis on geographical expansion.
The report presents a comprehensive assessment of the global market by offering valuable insights, facts, industry-related information, and historical data. Several methodologies and approaches are adopted to make meaningful assumptions and views. Furthermore, the report offers a detailed analysis and information as per the market segments, helping our readers to get a comprehensive overview of the global market.
To gain extensive insights into the market, Request for Customization
Along with this, the report provides an elaborative analysis of the subdural electrode market dynamics and competitive landscape. Various key insights presented in the report are the prevalence of epilepsy for key countries, key industry developments: mergers, acquisitions & partnerships, regulatory scenarios, overview: applications of subdural electrodes in cranial nerves & others, and trends of usage of subdural electrodes and intracranial monitoring in epilepsy surgery.
ATTRIBUTE | DETAILS |
Study Period | 2015-2026 |
Base Year | 2018 |
Forecast Period | 2019-2026 |
Historical Period | 2015-2017 |
Unit | Value (USD Million) |
Segmentation | By Type
|
By Material
| |
By End User
| |
By Region/Country
|
Fortune Business Insights says that the subdural electrode market is projected to reach USD 53.2 Million by 2026.
The value of the U.S. subdural electrode market was USD 11.4 Million in 2018.
The subdural electrode market is projected to grow at a CAGR of 8.1% during the forecast period (2019-2026).
The depth electrodes segment is the leading segment in the subdural electrodes market
The increasing demand for intracranial monitoring and superior procedural outcomes of subdural electrodes in brain mapping are the key factors driving the subdural electrodes market.
Ad-Tech Medical Instrument Corporation, CorTec GmbH, and Integra LifeSciences Corporation are the top players in the subdural electrode market.
The U.S. is expected to hold the highest market share in the subdural electrodes market.
Increasing prevalence of epilepsy and rising adoption of epileptic surgeries are the factors that are expected to drive the adoption of subdural electrodes.
Gradual shift from strip/grid electrodes to depth electrodes and 4 dimensional brain mapping are the key trends of subdural electrode market.